Decrease of ventral tegmental area dopamine neuronal activity in nicotine withdrawal rats

NeuroReport

Volumn 15, Issue 9, 2004, Pages 1479-1481

  Liu, Zhong Hua ^a   Jin, Wen Qiao ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Dopamine; Electrophysiology; Nicotine; Ventral tegmental area; Withdrawal

Indexed keywords

DOPAMINE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOSE TIME EFFECT RELATION; DRUG WITHDRAWAL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECORDING; REINFORCEMENT; VENTRAL TEGMENTUM; WITHDRAWAL REFLEX;

ANIMALS; DOPAMINE; ELECTROPHYSIOLOGY; MALE; NEURONS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER; VENTRAL TEGMENTAL AREA;

EID: 3142783356     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000126218.25235.b6     Document Type: Article

References (21)

1. Miyata H and Yanagita T. Neurobiological mechanisms of nicotine craving. Alcohol 2001; 24:87-93.
2. Wise RA. Drug-activation of brain reward pathways. Drug Alcohol Depend 1998; 51:13-22.
3. Erhardt S, Schwieler L and Engberg G. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine. Synapse 2002; 43:227-237.
4. Fisher JL, Pidoplichko VI and Dani JA. Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons. J Physiol 1998; 92:209-213.
5. Yin R and French ED. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res Bull 2000; 51:507-514.
6. Pontieri FE, Tanda G, Orzi F and Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996; 382:255-257.
7. Lapin EP, Maker HS, Sershen H and Lajtha A. Action of nicotine on accumbens dopamine and attenuation with repeated administration. Eur J Pharmacol 1989; 160:53-59.
8. Rada P, Jensen K and Hoebel BG. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens. Psychopharmacology 2001; 157:105-110.
9. Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B and Svensson TH. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Res 1998; 779:214-225.
10. Hildebrand BE, Panagis G, Svensson TH and Nomikos GG. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacology 1999; 21:560-574.
11. Carboni E, Bortone L, Giua C and Di Chiara G. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend 2000; 58:93-102.
12. Fung YK, Schmid MJ, Anderson TM and Lau YS. Effects of nicotine withdrawal on central dopaminergic systems. Pharmacol Biochem Behav 1996; 53:635-640.
13. Suzuki T, Ise Y, Tsuda M, Maeda J and Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 1996; 314:281-284.
14. Epping-Jordan MP, Watkins SS, Koob GF and Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 1998; 393:76-79.
15. Rasmussen K and Czachura JF. Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons. Neuroreport 1995; 7:329-332.
16. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. London: Academic Press; 1986.
17. Grace AA and Bunney BS. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 1983; 10:301-315.
18. Diana M, Pistis M, Muntoni A and Gessa G. Profound decrement of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J Pharmacol Exp Ther 1995; 272:781-785.
19. Diana M, Melis M, Muntoni AL and Gessa GL. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci USA 1998; 95: 10269-10273.
20. Diana M, Pistis M, Carboni S, Gessa GL and Rossetti Z. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci USA 1993; 90:7966-7969.
21. Benwell MEM and Balfour DJK. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 1992; 105:849-856.